Skip to main content
SpringerLink
Log in

Behandlung älterer Myelompatienten

Therapie mit Lenalidomid und Dexamethason auch im höheren Alter wirksam

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Hulin C et al. J Clin Oncol. 2016 Jun 20. pii: JCO667295. [Epub ahead of print].

    Google Scholar 

  2. Palumbo A et al. Blood. 2015;125(13):2068–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Palumbo A et al. Blood. 2011;118(17):4519–2.

    Article  CAS  PubMed  Google Scholar 

Originalie

  • Hulin C et al. Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial. J Clin Oncol. 2016 Jun 20. pii: JCO667295. [Epub ahead of print].

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Med. Klinik V des Universitätsklinikums Heidelberg und des Nationalen Centrums für Tumorerkrankungen (NCT), Heidelberg, Deutschland

    Hartmut Goldschmidt

Authors
  1. Hartmut Goldschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hartmut Goldschmidt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goldschmidt, H. Therapie mit Lenalidomid und Dexamethason auch im höheren Alter wirksam. Info Onkol. 20, 10–11 (2017). https://doi.org/10.1007/s15004-017-5652-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-017-5652-5

Schlüsselwörter

Search

Navigation